Belluscura plc is an English company that is focused on improving healthcare and people’s lives by developing new and innovative enriched oxygen treatment platforms. We are developing proprietary oxygen enrichment technologies that can be applied across a range of treatment possibilities.
We are focused on novel oxygen-based treatment platforms that can be adapted and applied in a wide range of markets beyond those traditionally applicable to a single product or product line. Providing innovative enriched oxygen treatment platforms in large markets benefits the entire healthcare universe by reducing the cost of treatment and increasing the available treatment options.
At the same time, it is critical that we innovate and commercialize rapidly, identifying those oxygen enrichment platforms that can make a significant improvement while also having a clear regulatory clearance path.